Scleroderma, Limited
Immunology·MeSH: Scleroderma, Limited
Prevalence
200.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Scleroderma, Limited?
There are 1 clinical trial targeting Scleroderma, Limited tracked by BioSniper.
What is the prevalence of Scleroderma, Limited?
The estimated prevalence of Scleroderma, Limited is approximately 200.0 per 100,000 population.
Deep-dive into Scleroderma, Limited
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis